Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:09 pm Purchase | 2025-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Nantahala Capital Management LLC | 2,449,468 2.800% | 205,149 (+9.14%) | Filing History |
| 2026-02-13 5:09 pm Sale | 2025-12-31 | 13G | VERASTEM INC VSTM | Nantahala Capital Management LLC | 3,795,473 4.720% | -830,763 (-17.96%) | Filing History |
| 2026-02-13 5:08 pm Purchase | 2025-12-31 | 13G | GOGO INC GOGO | Nantahala Capital Management LLC | 6,792,649 5.070% | 6,792,649 (New Position) | Filing History |
| 2026-02-13 5:08 pm Sale | 2025-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management LLC | 1,953,045 4.710% | -1,232,519 (-38.69%) | Filing History |
| 2026-02-13 5:07 pm Purchase | 2025-12-31 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 2,281,040 9.990% | 425,049 (+22.90%) | Filing History |
| 2026-02-13 5:07 pm Purchase | 2025-12-31 | 13G | HAIN CELESTIAL GROUP INC. HAIN | Nantahala Capital Management LLC | 6,528,789 7.210% | 6,528,789 (New Position) | Filing History |
| 2026-02-13 5:06 pm Sale | 2025-12-31 | 13G | SAVARA INC SVRA | Nantahala Capital Management LLC | 7,344,783 3.610% | -1,430,592 (-16.30%) | Filing History |
| 2026-02-13 5:06 pm Purchase | 2025-12-31 | 13G | FOX FACTORY HOLDING CORP COM FOXF | Nantahala Capital Management LLC | 2,188,300 5.240% | 2,188,300 (New Position) | Filing History |
| 2026-02-13 5:06 pm Purchase | 2025-12-31 | 13G | OPUS GENETICS, INC. IRD | Nantahala Capital Management LLC | 7,123,506 9.990% | 873,207 (+13.97%) | Filing History |
| 2026-02-13 5:06 pm Sale | 2025-12-31 | 13G | ESTABLISHMENT LABS HLDGS INC C ESTA | Nantahala Capital Management LLC | 987,689 3.500% | -985,803 (-49.95%) | Filing History |
| 2026-02-13 5:05 pm Purchase | 2025-12-31 | 13G | KORRO BIO INC KRRO | Nantahala Capital Management LLC | 600,000 6.370% | 600,000 (New Position) | Filing History |
| 2026-02-13 5:05 pm Purchase | 2025-12-31 | 13G | ELUTIA INC ELUT | Nantahala Capital Management LLC | 4,124,854 9.990% | 435,787 (+11.81%) | Filing History |
| 2026-02-13 5:05 pm Sale | 2025-12-31 | 13G | IMMUNIC INC IMUX | Nantahala Capital Management LLC | 10,378,406 8.220% | -256,159 (-2.41%) | Filing History |
| 2026-02-13 5:05 pm Purchase | 2025-12-31 | 13G | EDESA BIOTECH INC EDSA | Nantahala Capital Management LLC | 855,583 9.990% | 155,095 (+22.14%) | Filing History |
| 2026-02-13 5:04 pm Purchase | 2025-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Nantahala Capital Management LLC | 7,037,916 5.680% | 1,739,292 (+32.83%) | Filing History |
| 2026-02-13 5:04 pm Purchase | 2025-12-31 | 13G | DARIOHEALTH CORP COM PAR 0.000 DRIO | Nantahala Capital Management LLC | 688,673 9.990% | 119,829 (+21.07%) | Filing History |
| 2026-02-13 5:04 pm Purchase | 2025-12-31 | 13G | HERBALIFE LTD HLF | Nantahala Capital Management LLC | 8,681,857 8.400% | 1,559,559 (+21.90%) | Filing History |
| 2026-02-13 5:03 pm Sale | 2025-12-31 | 13G | DHI GROUP INC DHX | Nantahala Capital Management LLC | 2,374,027 5.030% | -2,579 (-0.11%) | Filing History |
| 2026-02-13 5:03 pm Purchase | 2025-12-31 | 13G | BIOMX INC PAR $0.0001 PHGE | Nantahala Capital Management LLC | 156,696 9.990% | 25,422 (+19.37%) | Filing History |
| 2026-02-13 5:02 pm Purchase | 2025-12-31 | 13G | BIOVENTUS INC BVS | Nantahala Capital Management LLC | 6,047,403 9.030% | 766,561 (+14.52%) | Filing History |